Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Regulatory News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants

28 May 2019 07:30

RNS Number : 2182A
Integumen PLC
28 May 2019
 

 

 

28 May 2019

Integumen PLC

("Integumen" or "Company")

 

Exercise of Warrants

 

Integumen (AIM : SKIN) announces that it has received notification from a warrant holder to exercise warrants over 1,000,000 shares of 0.01p each in the share capital of Integumen ("New Ordinary Shares"). The consideration for the exercise of the New Ordinary Shares amounts, in aggregate, to a cash value of £15,000.

 

The New Ordinary Shares are expected to be admitted to trading on AIM on or around 31 May 2019, and will rank pari passu with the ordinary shares of the Company in issue.

 

Total voting rights

 

The Company's total issued capital, after the issue of the New Ordinary Shares, will be 954,173,684 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

Contacts

 

Integumen plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 643

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker

+44 (0) 20 3621 4120

 

About Integumen:

 

Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

 

The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEEDLFLKEFXBBB
Date   Source Headline
2nd Oct 20204:51 pmRNSRule 2.9 Announcement - update
2nd Oct 20204:45 pmRNSExercise of Warrants and Total Voting Rights
1st Oct 20205:02 pmRNSForm 8.3 - Integumen Plc
30th Sep 20205:45 pmRNSForm 8.3 - Integumen plc
30th Sep 20207:00 amRNS“First US Integumen COVID19 detection agreement”
28th Sep 20204:46 pmRNSForm 8.3 - Integumen PLC
28th Sep 20204:40 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
25th Sep 20204:36 pmRNSPrice Monitoring Extension
25th Sep 20203:36 pmRNSRule 2.9 Announcement - update
25th Sep 20203:35 pmRNSExercise of Warrants and Total Voting Rights
25th Sep 20209:05 amRNSSecond Price Monitoring Extn
25th Sep 20209:00 amRNSPrice Monitoring Extension
25th Sep 20208:47 amRNSForm 8.3 - Integumen plc
25th Sep 20208:18 amRNSForm 8.3 - Integumen Plc
25th Sep 20207:00 amRNSOffer Update
24th Sep 20202:05 pmRNSSecond Price Monitoring Extn
24th Sep 20202:00 pmRNSPrice Monitoring Extension
24th Sep 20201:01 pmRNSResult of AGM
24th Sep 20207:00 amRNSUnveiling of new breath test/dig'l health platform
23rd Sep 20209:05 amRNSSecond Price Monitoring Extn
23rd Sep 20209:00 amRNSPrice Monitoring Extension
22nd Sep 20205:33 pmRNSForm 8.3 - Integumen PLC
21st Sep 20204:43 pmRNSForm 8.3 - Integumen Plc
18th Sep 20205:23 pmRNSIssue of Share Options
18th Sep 20207:00 amRNSInterim Results
17th Sep 20203:23 pmRNSForm 8.3 - Integumen PLC
17th Sep 202012:10 pmRNSForm 8.3 - Integumen PC
16th Sep 20203:40 pmRNSRule 2.9 Announcement - update
16th Sep 20203:35 pmRNSExercise of Warrants and Total Voting Rights
16th Sep 20201:06 pmRNSRule 2.9 Announcement - update
16th Sep 20209:12 amRNSRule 2.9 Announcement - update
15th Sep 20201:40 pmRNSResult of General Meeting
14th Sep 20204:18 pmRNSForm 8.3 - Integumen PLC
14th Sep 202012:30 pmRNSForm 8.3 - Integumen PLC
14th Sep 202010:44 amRNSForm 8 (OPD) - Modern Water plc
14th Sep 202010:42 amRNSForm 8 (OPD) - Modern Water plc
11th Sep 20202:01 pmRNSForm 8 (OPD) - Modern Water plc
11th Sep 20202:00 pmRNSForm 8 (OPD) - Integumen plc
10th Sep 20204:40 pmRNSSecond Price Monitoring Extn
10th Sep 20204:35 pmRNSPrice Monitoring Extension
10th Sep 20202:01 pmRNSRule 2.9 Announcement - update
10th Sep 20202:00 pmRNSExercise of Warrants; Total Voting Rights
9th Sep 20204:44 pmRNSForm 8.3 - Integumen Plc
9th Sep 202012:04 pmRNSReplacement: Form 8.3 - Integumen plc
8th Sep 20204:36 pmRNSRule 2.9 Announcement - update
8th Sep 20204:35 pmRNSExercise of Warrants; Total Voting Rights
8th Sep 20204:21 pmRNSOfferor - Integumen Plc
8th Sep 20204:01 pmRNSForm 8.3 - Offeree - Modern Water Plc
8th Sep 20207:35 amRNSForm 8.3 - Integumen plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.